As insulin, and possibly also lipids may be a confounders in the models, related to POPs [32], PFAAs [34] and NAFLD [4], they can be expected to have an impact on the effect estimates but less so on their precision. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.